SCHEMBL4287006

SCHEMBL4287006

COc1ccc(C(=O)c2c(O)cc(CO)cc2F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
SLC5A1 P13866 1/20 0.45
SLC5A2 P31639 1/20 0.45
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
APP P05067 1/20 0.43
PARP10 Q53GL7 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4279729 0.86 KDM4E (0.49) SLC5A1SLC5A2ALDH1A1PARP10LMNA
SCHEMBL4282675 0.85 PARP10 (0.47) PARP10RAB9AKMT2AHPGDNPC1
SCHEMBL4281069 0.84 CYP3A4 (0.56) NFKB1NFKB2RELACYP3A4CYP2D6
SCHEMBL4279702 0.84 NFKB1 (0.45) NFKB1NFKB2RELACYP3A4CYP2D6
SCHEMBL4287058 0.84 SLC5A1 (0.48) NFKB1NFKB2RELASLC5A1SLC5A2
SCHEMBL38661406 0.84 CYP2D6 (0.54) NFKB1NFKB2RELACYP3A4CYP2D6
SCHEMBL4287423 0.83 MEN1 (0.50) NFKB1NFKB2RELACYP3A4CYP2D6
SCHEMBL4288308 0.83 HPGD (0.50) NFKB1NFKB2RELACYP3A4CYP2D6
SCHEMBL4283203 0.81 MEN1 (0.47) CYP3A4CYP2D6CYP2C19ALDH1A1GAA
SCHEMBL8132899 0.75 MKNK2 (0.52) CYP3A4CYP2D6CYP2C19ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 NFKB1 2608/4885NFKB2 1814/4885RELA 513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.